Interview with Anigent Chief Product Officer & Managing Partner Charles D'AmatoInterview with Anigent Chief Product Officer & Managing Partner Charles D'Amato
Drug Diversion Insights with Terri Vidals
Terri Vidals and Charles D'Amato discuss Anigent's innovative drug diversion monitoring software and its success at Mayo Clinic Arizona.
27:36•24 Feb 2022
Anigent's Innovative Approach to Drug Diversion: A Conversation with Charles D'Amato
“What the difference is is that we're able to actually identify diverters versus just providing a bunch of data to that end user, that auditor, and having them have to go and try to determine who their highest risk individual is.”
When it comes to tackling drug diversion in healthcare, innovation is key. In this episode, Terri Vidals sits down with Charles D'Amato, the Chief Product Officer and Managing Partner of Anigent, to discuss their groundbreaking software designed for drug diversion monitoring. Developed by a pharmacist with extensive clinical and operational experience, Anigent's software stands out for its predictive analytics capabilities.
D'Amato shares insights into how the software doesn't just flag potential issues but actually identifies individuals at risk of diverting drugs. He also highlights its successful implementation at Mayo Clinic Arizona, emphasizing the importance of proactive measures and a culture of constant vigilance in preventing drug diversion. If you're a healthcare professional looking to enhance your facility's drug safety protocols, this conversation offers valuable perspectives and practical advice.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.